 |
|
| Blog results | Results 1 - 10 of about 17,424 for sibutramine hydrachloride. (0.30 seconds) |
| Sorted by relevance Sort by date |
| 19 Nov 2009 FDA notified healthcare professionals and patients that it is reviewing preliminary data from a recent study suggesting that patients using sibutramine have a higher number of cardiovascular events (heart attack, stroke, ... Drugs.com - FDA MedWatch Alerts - http://www.drugs.com/fda_alerts.html - References [ More results from Drugs.com - FDA MedWatch Alerts ] |
| 4 Dec 2009 by pillscribe Abbott lauched a study to analyze the risk of cardiovascular-related problems of Meridia (sibutramine hydrochloride monohydrate) in 2003 at the request of European regulators. Abbott's Meridia (sibutramine hydrochloride monohydrate), ... DWS Pill Scribe - http://www.dancewithshadows.com/pillscribe/ [ More results from DWS Pill Scribe ] |
| 19 Nov 2009 by admin Meridia (sibutramine hydrochloride): Early Communication about an Ongoing Safety Review. Audience: Cardiology and endocrinology healthcare professionals. FDA notified healthcare professionals and patients that it is reviewing ... Attorney At Law - http://www.attorneyatlaw.com/ [ More results from Attorney At Law ] |
| 23 Nov 2009 by Bill Meridia (sibutramine hydrochloride): Early Communication about an Ongoing Safety Review. November 23, 2009 by Bill Filed under Health. FDA is reviewing preliminary data from a recent study suggesting that patients using sibutramine have ... Consumer News - http://blog.preferredconsumer.com/ |
| 21 Nov 2009 by salud equitativa Drug Information Update- Early Communication about an Ongoing Safety Review of Meridia (sibutramine hydrochloride) FDA is reviewing preliminary data from a recent study suggesting that patients using sibutramine have a higher number of ... CIENCIASMEDICASNEWS - http://elbiruniblogspotcom.blogspot.com/ |
| 20 Nov 2009 Meridia (sibutramine hydrochloride): Early Communication about an Ongoing Safety Review. FDA MedWatch · FDA News · FDA is reviewing preliminary data from a recent study suggesting that patients using sibutramine have a higher number of ... Pharmainfo.net - http://www.pharmainfo.net/ |
| 23 Nov 2009 by Liz Jones Early Communication about an Ongoing Safety Review of Meridia (sibutramine hydrochloride) This information reflects FDA's current analysis of available data concerning this drug. FDA is considering, but has not reached a conclusion ... Press Releases - http://www.fiercebiotech.com/press-releases |
| 20 Nov 2009 by RecallAware FDA is reviewing preliminary data from a recent study suggesting that patients using sibutramine have a higher number of cardiovascular events (heart attack, Recall Aware - http://www.recallaware.com/ |
| 30 Nov 2009 by Tom Lamb On November 20, 2009 the FDA issued an "Early Communication about an Ongoing Safety Review of Meridia (sibutramine hydrochloride)" to let patients and their doctors know about a possible increased risk for adverse cardiovascular events ... Drug Injury Watch - http://www.drug-injury.com/ |
| 20 Nov 2009 by admin ... of cardiovascular events (heart attack, stroke, resuscitated cardiac arrest, or death) than patients using a placebo. Read the original here: Meridia (sibutramine hydrochloride): Early Communication about an Ongoing Safety Review. All about healthy eating and slimming. - http://news.jade-bokie.info/ [ More results from All about healthy eating and slimming. ] |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
